New

South America Radiopharmaceuticals Market

2021

South America Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025882 | No. of Pages: 130 | Category: Pharmaceuticals | Status: Published

Market Insights

South America Radiopharmaceuticals Market to Grow at a CAGR of 8.1% to reach US$ 946.54 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The SAM radiopharmaceuticals market is expected to grow from US$ 547.43 million in 2021 to US$ 946.54 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2021 to 2028.


Brazil and Argentina are major economies in SAM. Suitability of alpha radio immunotherapy in targeted cancer treatment is expected to fuel the market growth. The Targeted alpha therapy (TAT) is the latest and evolving technique used for local and systemic cancer treatment. Preclinical research and clinical trials prove that alpha-emitting radionuclides kill targeted cancer cells and do not harm the healthy cells (selective cytotoxicity). 211At, 213Bi, 225Ac, and 227Th are among the alpha-emitting radioisotopes used to label targeting vectors such as monoclonal antibodies; the monoclonal antibodies labeled with α-emitting radionuclides are emerging as an effective radioimmunotherapy. Shorter-range radioisotopes (α particles) are used for treating patients with hematological cancer. Alpha radiations are suitable for killing isolated cancer cells in the vascular and lymphatic systems as well as in regressing tumors by disturbing tumor capillary networks for targeting and killing tumor capillary endothelial cells (ECs). The Radium-223 dichloride alpha therapy is the only approved concept for internal alpha-emitting radioisotope cancer treatment. The decay of radioactive elements after reaching the malignant tissue releases tumor-destroying radiations without causing significant damage to the adjoining healthy tissues. The alpha radiations are much localized, and they penetrate a maximum of 2–10 cell layers. Healthy cells in the surrounding tissue can recover from any damage caused by the radiation to a certain extent themselves. Nuclear imaging uses gamma emitters that have a long lifespan, which allows blood clearance as the tumor increases its uptake of the conjugate over time, so improving contrast. Nuclear imaging agents allow the diagnosis of tumor and organs. In addition, the rise in awareness about alpha radioimmunotherapy and surge in the availability of therapies for cancer treatment procedures are propelling the demand for nuclear imaging. Thus, the preferred use of alpha radioimmunotherapy in the treatment of cancer is fueling the SAM radiopharmaceuticals market growth.

In case of COVID-19, SAM is highly affected especially Brazil, followed by Peru, Chile, Ecuador, and Venezuela. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the South American countries. According to the International Council of Nurses, the number of deaths of health professionals in Brazil are above other countries due to high transmission of the virus. Brazil has many populated regions with small houses with 6-7 people per house, the virus spreads like wildfire. Currently, the countries in this region are rapidly increasing its clinical programs to fight against the novel corona virus. In this scenario, Brazil has observed enormous difficulties in management of chronic neurological disorders, from headache to neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their neurological disease. During the pandemic, stroke patients as well as other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of the diseases during the acute phase. These factors are likely to have negative impact on the market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM radiopharmaceuticals market. The SAM radiopharmaceuticals market is expected to grow at a good CAGR during the forecast period.
SAM radiopharmaceuticals market

Get more information on this report :


SAM Radiopharmaceuticals Market Segmentation

SAM Radiopharmaceuticals Market – By Type

  • Diagnostic Nuclear Medicine
    • SPECT
    • PET
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
    • Beta Emitters
    • Brachytherapy Isotopes

SAM Radiopharmaceuticals Market – By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

SAM Radiopharmaceuticals Market – By End User

  • Hospitals
  • Imaging Centers
  • Academic and Research Centers
  • Others

SAM Radiopharmaceuticals Market, by Country

  • Brazil
  • Argentina
  • Rest of SAM

SAM Radiopharmaceuticals Market -Companies Mentioned

  • Cardinal Health Inc
  • Curium
  • GENERAL ELECTRIC
  • Lantheus Medical Imaging, Inc.
  • Bayer AG
  • Bracco Imaging S.p.A
  • Nordion

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Radiopharmaceuticals Market – By Type

1.3.2 SAM Radiopharmaceuticals Market – By Application

1.3.3 SAM Radiopharmaceuticals Market – By End User

1.3.4 SAM Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Suitability of Alpha Radio Immunotherapy in Targeted Cancer Treatment.

5.1.2 Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Availability of Substitutes

5.3 Market Opportunities

5.3.1 High Growth Potential in Developing Countries

5.4 Future Trends

5.4.1 Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– SAM Analysis

6.1 SAM Radiopharmaceuticals Market Revenue Forecast and Analysis

7. SAM Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 SAM Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. SAM Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 SAM Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. SAM Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 SAM Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. SAM Radiopharmaceuticals Market – Country Analysis

10.1 SAM: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 SAM: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Brazil Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Brazil: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Brazil: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Brazil Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Argentina Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 Argentina: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 Argentina: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 Argentina Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.3 Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 Rest of SAM Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 Rest of SAM: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 Rest of SAM: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 Rest of SAM Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 Rest of SAM Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on SAM Radiopharmaceuticals Market

11.1 SAM: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nordion

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. SAM Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Brazil Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Brazil Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Argentina Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. Argentina Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Argentina Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of SAM Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. Rest of SAM Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. Rest of SAM Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. Rest of SAM Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of SAM Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Recent Inorganic Growth Strategies

Table 18. Recent Organic Growth Strategies

Table 19. Glossary of Terms

LIST OF FIGURES

Figure 1. SAM Radiopharmaceuticals Market Segmentation

Figure 2. SAM Radiopharmaceuticals Market Segmentation, By Country

Figure 3. SAM Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. Brazil to Show Significant Growth During Forecast Period

Figure 6. SAM PEST Analysis

Figure 7. SAM Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. SAM Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. SAM Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. SAM Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. SAM SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. SAM PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. SAM Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. SAM Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. SAM Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. SAM Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. SAM Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. SAM Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. SAM Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. SAM Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. SAM Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. SAM Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. SAM Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. SAM Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. SAM Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. SAM Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. SAM: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. SAM: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 30. Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 31. Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in SAM Market

  1. Cardinal Health Inc
  2. Curium
  3. GENERAL ELECTRIC
  4. Lantheus Medical Imaging, Inc.
  5. Bayer AG
  6. Bracco Imaging S.p.A
  7. Nordion
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM radiopharmaceuticals market.              
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it 
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025882
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.